Active Ingredient: POSACONAZOLE
Proprietary Name: POSACONAZOLE
Dosage Form; Route of Administration: TABLET, DELAYED RELEASE; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A212226
Product Number: 001
Approval Date: May 10, 2022
Applicant Holder Full Name: SPECGX LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
